Zymergen Stock

zymergen.com/BioTechFounded: 2013Funding to Date: $920.06MM

Zymergen is a developer of unique materials and products for a range of industries – from agriculture to electronics, consumer care to pharmaceuticals, and more.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Zymergen, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Joshua Hoffman
Chief Executive Officer
Zach Serber
Chief Science Officer and Founder
Jed Dean
VP of Operations and Engineering
Aaron Kimball
Chief Technical Officer
Judy Gilbert
Chief People Officer
Richard Pieters
President, Products
Enakshi Singh
VP of Finance
Jack Gold
Chief Marketing Officer
Mina Kim
Chief Legal Officer

Board Members

Joshua Hoffman
Jay T. Flatley
Illumina Inc
Steven Chu
Stanford University
Jed Dean
Deep Nishar
Soft Group International
Matt Ocko
DCVC
Sandra E. Peterson
Clayton, Dubilier & Rice, LLC
Rohit Sharma
True Ventures

Other companies like Zymergen in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

SAN FRANCISCO, Sept. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses...
LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 4, 2021 deadline to file...
NEW YORK, Aug. 22, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against...